自身免疫性肝炎中肝脏CD69+CD103+CD8+组织驻留记忆T细胞的临床意义
该研究探讨了CD69+CD103+CD8+组织驻留记忆T细胞(TRM)在自身免疫性肝炎(AIH)中的临床意义。研究发现AIH患者肝脏中CD8+ TRM细胞显著增加,与疾病严重程度相关,且免疫抑制治疗成功后其频率下降。糖皮质激素通过抑制IL-15和TGF-β诱导的CD8+ TRM细胞扩增及下调Blimp1发挥抗炎作用。
要点
- AIH患者肝脏CD8+ TRM细胞显著高于慢性乙肝、NAFLD和健康对照。
- CD8+ TRM细胞升高与AIH疾病严重程度显著相关。
- 糖皮质激素通过抑制CD8+ TRM细胞扩增减轻肝脏炎症。
核心结论
- CD8+ TRM细胞在AIH发病中起关键作用,糖皮质激素通过直接抑制其扩增减轻肝脏炎症。
研究设计与样本
- 比较AIH患者与慢性乙肝、NAFLD及健康对照肝组织中CD8+ TRM细胞频率,并分析其与疾病严重程度及免疫抑制治疗反应的关系;体外研究糖皮质激素对CD8+ TRM细胞扩增的影响。
主要发现
- AIH患者肝脏CD69+CD103+CD8+ TRM细胞较慢性乙肝、NAFLD和健康对照显著增加。
- CD8+ TRM细胞升高与AIH疾病严重程度显著统计学相关。
- 免疫抑制治疗成功的AIH患者肝脏CD8+ TRM细胞频率显著下降。
- AIH患者炎症细胞IL-15和TGF-β表达升高,肝脏E-钙黏蛋白广泛表达。
- 糖皮质激素体外抑制IL-15和TGF-β诱导的CD8+ TRM细胞扩增,并直接下调其Blimp1。
临床怎么用
- 肝脏CD8+ TRM细胞可能作为AIH疾病严重程度的潜在生物标志物。
- 糖皮质激素通过抑制CD8+ TRM细胞扩增发挥治疗AIH的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The diverse inflammatory response found in the liver of patients with autoimmune hepatitis (AIH) is well established, but identification of potentially pathogenic subpopulations has proven enigmatic. APPROACH AND RESULTS: We report herein that CD69+ CD103+ CD8+ tissue-resident memory T cells (TRM ) are significantly increased in the liver of patients with AIH compared to chronic hepatitis B, NAFLD, and healthy control tissues. In addition, there was a significant statistical correlation between elevation of CD8+ TRM cells and AIH disease severity. Indeed, in patients with successful responses to immunosuppression, the frequencies of such hepatic CD8+ TRM cells decreased significantly. CD69+ CD8+ and CD69+ CD103+ CD8+ T cells, also known as CD8+ TRM cells, reflect tissue residency and are well known to provide intense immune antigenic responses. Hence, it was particularly interesting that patients with AIH also manifest an elevated expression of IL-15 and TGF-β on inflammatory cells, and extensive hepatic expression of E-cadherin; these factors likely contribute to the development and localization of CD8+ TRM cells. Based on these data and, in particular, the relationships between disease severity and CD8+ TRM cells, we studied the mechanisms involved with glucocorticoid (GC) modulation of CD8+ TRM cell expansion. Our data reflect that GCs in vitro inhibit the expansion of CD8+ TRM cells induced by IL-15 and TGF-β and with direct down-regulation of the nuclear factor Blimp1 of CD8+ TRM cells. CONCLUSIONS: Our data suggest that CD8+ TRM cells play a critical role in the pathogenesis of AIH, and GCs attenuate hepatic inflammation through direct inhibition of CD8+ TRM cell expansion.
引用
- You Z, Li Y, Wang Q, et al. The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis. Hepatology. 2021. PMID: 33554350. doi:10.1002/hep.31739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。